文献
J-GLOBAL ID:202202210258047586
整理番号:22A0443110
JAM2は乳癌においてEMT経路を抑制することにより良好な予後を予測し浸潤と移動を阻害する【JST・京大機械翻訳】
JAM2 predicts a good prognosis and inhibits invasion and migration by suppressing EMT pathway in breast cancer
著者 (8件):
Peng Yang
(Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
,
Li Han
(Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
,
Fu Yong
(Department of Breast Surgery, Dianjiang People’s Hospital of Chongqing, Chongqing 408300, China)
,
Guo Shipeng
(Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
,
Qu Chi
(Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
,
Zhang Yingzi
(Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
,
Zong Beige
(Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
,
Liu Shengchun
(Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
資料名:
International Immunopharmacology
(International Immunopharmacology)
巻:
103
ページ:
Null
発行年:
2022年
JST資料番号:
T0026B
ISSN:
1567-5769
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)